Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Ketamine for Depression: Advances in Clinical Treatment, Rapid Antidepressant Mechanisms of Action, and a Contrast with Serotonergic Psychedelics

Current topics in behavioral neurosciences(2022)10.1007/7854_2022_313Source: DataRank Database

Ketamine for Depression: Advances in Clinical Treatment, Rapid Antidepressant Mechanisms of Action, and a Contrast with Serotonergic Psychedelics is a research paper published in Current topics in behavioral neurosciences (2022). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 15.33)OA: greenTopics (29)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Johan Saelens,Bashkim Kadriu ORCID,Carlos A. Zarate ORCID,Christoph Kraus ORCID,Marina Kojic

Live enrichment

PubMed:35312993 PMC:PMC10500612 OpenAlex:https://openalex.org/W4220759286

Intramural NIH HHS

Grant: ZIA MH002857

FWCI

15.33

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: https://www.springer.com/tdm

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10500612/pdf/nihms-1929971.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/7854_2022_313

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10500612

book serieshttps://doi.org/10.1007/7854_2022_313

Fields of Study

Psychedelics and Drug StudiesTreatment of Major DepressionTryptophan and brain disorders

MeSH Terms

Antidepressive AgentsDepressionHallucinogensKetamineReceptors, N-Methyl-D-Aspartate

Keywords

SerotonergicAntidepressantKetamineNeuroscienceGlutamatergicMechanism of actionMechanism (biology)PsychologyPharmacologyMedicineGlutamate receptorHippocampusChemistryReceptorSerotoninInternal medicineGlutamateBrain-derived neurotrophic factorSynaptic plasticityAntidepressantsTreatment Resistant Depression

Sustainable Development Goals

SDG 0: Good health and well-being